UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000026133
Receipt number R000030029
Scientific Title The analysis of gut microbiome pre- and post-liver transplantation
Date of disclosure of the study information 2017/02/14
Last modified on 2017/02/14 17:56:33

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The analysis of gut microbiome pre- and post-liver transplantation

Acronym

The analysis of gut microbiome pre- and post-liver transplantation

Scientific Title

The analysis of gut microbiome pre- and post-liver transplantation

Scientific Title:Acronym

The analysis of gut microbiome pre- and post-liver transplantation

Region

Japan


Condition

Condition

Liver transplantation

Classification by specialty

Hepato-biliary-pancreatic medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To clarify the gut microbiome pre- and post- liver transplantation

Basic objectives2

Others

Basic objectives -Others

To examine the contribution of gut microbiome to clinical course

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

To clarify the gut microbiome pre- and post- liver transplantation

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Genders do not matter.
2. Patients who who will visit as outpatient or be admitted to Nagasaki university hospital.
3. Patients who will get colonoscopy in health insurance.
4. Patients providing written informed consent with their own will.

Key exclusion criteria

1. Patients with a high bleeding risk.
2. Patients with some diffuse lesions in clarge olon.
3. Patients with severe general complications
4. Patients who were judged to be inappropriate for this study.

Target sample size

50


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Satoshi Miuma

Organization

Nagasaki University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

Sakamoto 1-7-1, Nagasaki

TEL

0958197481

Email

miuma1002@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Satoshi Miuma

Organization

Nagasaki University Hospital

Division name

Department of Gastroenterology and Hepatology

Zip code


Address

1-7-1 Sakamoto, Nagasaki

TEL

0958197481

Homepage URL


Email

miuma1002@gmail.com


Sponsor or person

Institute

Nagasaki University Hospital

Institute

Department

Personal name



Funding Source

Organization

Nagasaki University Hospital

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2017 Year 02 Month 14 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2016 Year 04 Month 28 Day

Date of IRB


Anticipated trial start date

2016 Year 07 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Not particular


Management information

Registered date

2017 Year 02 Month 14 Day

Last modified on

2017 Year 02 Month 14 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030029


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name